Obagi Skintrinsiq Clarifiying Protocol

Product NDC
62032-909
11-digit product format
620320909
Labeler code
62032
Product ID
62032-909_a9c17c57-a3af-43d6-9db3-56fb8e28894b
Type
HUMAN OTC DRUG
Nonproprietary name
salicylic acid, titanium dioxide, and zinc oxide
Dosage form
KIT
Labeler
Obagi Cosmeceuticals LLC
Application
M020
Marketing category
OTC MONOGRAPH DRUG
Marketing start
2021-08-01
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Obagi Skintrinsiq Clarifiying Protocol
Listing expiration
2026-12-31

Harmonized Identifiers#

Field, Values table
FieldValues
Rxcui251577, 1235208

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
7792dadb-52b6-46b6-8fdf-80b1171065b5Product name120180810
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62032-612-04Obagi Skintrinsiq Clarifiying Protocol148 mL in 1 BOTTLE, PLASTICLIQUID148 mL20 mg in 1mL3
62032-811-09Obagi Skintrinsiq Clarifiying Protocol1 in 1 CARTONLOTION15.6 g in 100g3
62032-811-09Obagi Skintrinsiq Clarifiying Protocol85 g in 1 TUBELOTION85 g15.6 g in 100g3
62032-909-09Obagi Skintrinsiq Clarifiying Protocol1 in 1 BOXKIT13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62032-909OBAGI SKINTRINSIQ CLARIFIYING PROTOCOL (SALICYLIC ACID, TITANIUM DIOXIDE, AND ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC]3Current NDC, Legacy NDC, 4 package rows20250406_08ba9ea8-73fd-472b-9cc4-67df167352ec.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1235208CLENZIderm M.D. 2 % Pore Therapy Topical SolutionPSN08ba9ea8-73fd-472b-9cc4-67df167352ec3
251577salicylic acid 2 % Topical SolutionPSN08ba9ea8-73fd-472b-9cc4-67df167352ec3
1235208salicylic acid 20 MG/ML Topical Solution [Clenziderm]SBD08ba9ea8-73fd-472b-9cc4-67df167352ec3
251577salicylic acid 20 MG/ML Topical SolutionSCD08ba9ea8-73fd-472b-9cc4-67df167352ec3
1235208Clenziderm 20 MG/ML Topical SolutionSY08ba9ea8-73fd-472b-9cc4-67df167352ec3
1235208Clenziderm M.D. 2 % Pore TherapySY08ba9ea8-73fd-472b-9cc4-67df167352ec3
251577salicylic acid 2 % Topical SolutionSY08ba9ea8-73fd-472b-9cc4-67df167352ec3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
62032-612-0462032061204148 mL in 1 BOTTLE, PLASTIC148 mlHistorical
62032-811-09620320811091 in 1 CARTONHistorical
62032-909-09620320909091 KIT in 1 BOX (62032-909-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC1 kit2021-08-010000-00-00NoNoCurrent